Pacira Biosciences Inc

General ticker "PCRX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $860.6M

Pacira Biosciences Inc does not follow the US Stock Market performance with the rate: -37.6%.

Estimated limits based on current volatility of 2.1%: low 18.87$, high 19.69$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [19.22$, 35.83$]
  • 2024-12-30 to 2025-12-30 estimated range: [20.70$, 37.21$]

Financial Metrics affecting the PCRX estimates:

  • Positive: Non-GAAP EPS, $ of 2.92 > 2.29
  • Positive: 9.05 < Operating profit margin, % of 12.99
  • Positive: 7.18 < Operating cash flow per share per price, % of 11.35
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term PCRX quotes

Long-term PCRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $541.53MM $666.82MM $674.98MM
Operating Expenses $451.61MM $606.80MM $587.30MM
Operating Income $89.92MM $60.02MM $87.67MM
Non-Operating Income $-33.52MM $-46.72MM $-25.97MM
Interest Expense $31.75MM $39.98MM $20.31MM
R&D Expense $55.55MM $84.80MM $76.26MM
Income(Loss) $56.40MM $13.30MM $61.70MM
Taxes $14.42MM $-2.61MM $19.75MM
Profit(Loss) $41.98MM $15.91MM $41.95MM
Stockholders Equity $730.41MM $775.01MM $870.13MM
Inventory $98.55MM $96.06MM $104.35MM
Assets $2,075.35MM $1,681.20MM $1,574.39MM
Operating Cash Flow $125.72MM $145.27MM $154.65MM
Capital expenditure $45.87MM $30.08MM $15.16MM
Investing Cash Flow $-20.79MM $-225.19MM $77.54MM
Financing Cash Flow $380.69MM $-401.53MM $-183.03MM
Earnings Per Share* $0.95 $0.35 $0.91

* EPS are Split Adjusted, recent splits may be reflected with a delay.